These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

558 related items for PubMed ID: 6098048

  • 1. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M, Zahavi J, Kakkar VV.
    Thromb Haemost; 1984 Oct 31; 52(2):205-9. PubMed ID: 6098048
    [Abstract] [Full Text] [Related]

  • 2. The effect of pyridoxal-5-phosphate on the inhibition of platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation in human platelets.
    Zahavi M, Zahavi J, Kakkar VV.
    Life Sci; 1984 Oct 01; 35(14):1497-503. PubMed ID: 6090838
    [Abstract] [Full Text] [Related]

  • 3. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH, Haslam RJ.
    Mol Pharmacol; 1990 May 01; 37(5):671-81. PubMed ID: 2160060
    [Abstract] [Full Text] [Related]

  • 4. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets.
    Lam SC, Guccione MA, Packham MA, Mustard JF.
    Thromb Haemost; 1982 Apr 30; 47(2):90-5. PubMed ID: 6285543
    [Abstract] [Full Text] [Related]

  • 5. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
    Zahavi M, Welzel D, Wolf H, Honey A, Kakkar VV.
    Arzneimittelforschung; 1987 Jun 30; 37(6):669-74. PubMed ID: 2822055
    [Abstract] [Full Text] [Related]

  • 6. The effect of mitomycin C on platelet aggregation and adenosine 3',5'-monophosphate metabolism.
    Hashimoto S, Shibata S, Kobayashi B.
    Thromb Haemost; 1978 Feb 28; 39(1):177-85. PubMed ID: 205972
    [Abstract] [Full Text] [Related]

  • 7. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
    Miller OV, Gorman RR.
    J Cyclic Nucleotide Res; 1976 Feb 28; 2(2):79-87. PubMed ID: 177467
    [Abstract] [Full Text] [Related]

  • 8. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
    Ashida SI, Abiko Y.
    Thromb Haemost; 1979 Apr 23; 41(2):436-49. PubMed ID: 224522
    [Abstract] [Full Text] [Related]

  • 9. Effect of pyridoxal 5'-phosphate (PALP) on human platelet aggregation, dense granule release and thromboxane B2 generation--role of Schiff base formation.
    Krishnamurthi S, Westwick J, Kakkar VV.
    Thromb Haemost; 1982 Oct 29; 48(2):136-41. PubMed ID: 6891107
    [Abstract] [Full Text] [Related]

  • 10. Human platelet aggregation and cAMP system--cAMP level, adenyl cyclase, phosphodiesterase.
    Wang TY, Hussey CV, Sasse EA, Fobian JE.
    Ann Clin Lab Sci; 1978 Oct 29; 8(5):403-12. PubMed ID: 213009
    [Abstract] [Full Text] [Related]

  • 11. The effects of thrombin on adenyl cyclase activity and a membrane protein from human platelets.
    Brodie GN, Baenziger NL, Chase LR, Majerus PW.
    J Clin Invest; 1972 Jan 29; 51(1):81-8. PubMed ID: 4331802
    [Abstract] [Full Text] [Related]

  • 12. Cyclic 3',5'-adenosine monophosphate in human blood platelets. II. Effect of N6-2'-o-dibutyryl cyclic 3',5'-adenosine monophosphate on platelet function.
    Salzman EW, Levine L.
    J Clin Invest; 1971 Jan 29; 50(1):131-41. PubMed ID: 4322665
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivatives.
    Harris DN, Asaad MM, Phillips MB, Goldenberg HJ, Antonaccio MJ.
    J Cyclic Nucleotide Res; 1979 Jan 29; 5(2):125-34. PubMed ID: 221552
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
    Steen VM, Holmsen H.
    Thromb Haemost; 1984 Dec 29; 52(3):333-5. PubMed ID: 6099615
    [Abstract] [Full Text] [Related]

  • 15. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
    Seiler S, Brassard CL, Arnold AJ, Meanwell NA, Fleming JS, Keely SL.
    J Pharmacol Exp Ther; 1990 Dec 29; 255(3):1021-6. PubMed ID: 2175792
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Modulators of cyclic AMP systems.
    Hess SM, Chasin M, Free CA, Harris DN.
    Adv Biochem Psychopharmacol; 1975 Dec 29; (14):153-67. PubMed ID: 242200
    [Abstract] [Full Text] [Related]

  • 18. Effects of prostaglandins, derivatives of cyclic 3':5'-AMP, theophylline, cholinergic agents and colchicine on clot retraction in dilute platelet-rich plasma and gel-separated platelet test systems.
    Moake JL, Cimo PL, Widmer K, Peterson DM, Gum JR.
    Thromb Haemost; 1977 Aug 31; 38(2):420-8. PubMed ID: 202038
    [Abstract] [Full Text] [Related]

  • 19. Cyclic AMP turnover in response to prostaglandins in intact platelets: evidence for separate stimulatory and inhibitory prostaglandin receptors.
    Ashby B.
    Second Messengers Phosphoproteins; 1988 Aug 31; 12(1):45-57. PubMed ID: 2848122
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.